Renal Cancer
Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC) - Abstract
December 24, 2013
Sunitinib-related interstitial pneumonia after treatment with temsirolimus: A case of possible recall phenomenon - Abstract
December 24, 2013
Contrast enhanced ultrasonography prediction of cystic renal mass in comparison to histopathology - Abstract
December 24, 2013
Renal cell carcinoma metastases to gallbladder - Abstract
December 23, 2013
Contemporary management of renal cell carcinoma (RCC) in Victoria: Implications for longer term outcomes and costs - Abstract
December 23, 2013
Resection of isolated renal cell carcinoma metastases of the pancreas: Outcomes from the Johns Hopkins Hospital - Abstract
December 23, 2013
Ancillary diagnostic techniques in the evaluation of adult epithelial renal neoplasms: Indications, caveats, and pitfalls - Abstract
December 21, 2013
An analysis of respiratory induced kidney motion on four-dimensional computed tomography and its implications for stereotactic kidney radiotherapy - Abstract
December 21, 2013
Age distribution for partial and radical nephrectomy: Whose nephrons are being spared? - Abstract
December 20, 2013
Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group - Abstract
December 20, 2013
Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma - Abstract
December 19, 2013
Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy - Abstract
December 19, 2013
Imaging of primary and secondary renal lymphoma - Abstract
December 19, 2013
Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? - Abstract
December 18, 2013
Normothermic cardiopulmonary bypass with beating heart for management of renal cell carcinoma with atrial tumor thrombus - Abstract
December 18, 2013
A phase II study of bevacizumab and high-dose interleukin-2 in patients with metastatic renal cell carcinoma: A Cytokine Working Group (CWG) study - Abstract
December 18, 2013